Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.52 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | BCHE | P06276 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.48 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.48 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.48 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.47 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3307087 | 1.00 | NPC1 (0.52) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL9369351 | 1.00 | NPC1 (0.52) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL30739304 | 0.88 | MAPT (0.45) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL27963663 | 0.88 | MAPT (0.45) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL5677209 | 0.87 | MAOB (0.62) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL5677217 | 0.87 | MAOB (0.62) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL3123182 | 0.86 | PTGER3 (0.63) | PTGER4PTGER3PTGER2AKR1C3AKR1C2 | |
| SCHEMBL9789287 | 0.85 | MAPT (0.49) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL7559553 | 0.83 | RAB9A (0.59) | NPC1RAB9AMAPTLMNABCHE | |
| SCHEMBL7559547 | 0.83 | RAB9A (0.59) | NPC1RAB9AMAPTLMNABCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114796194-A | Application of DA adduct derived from Morus plant in preparation of beta-G inhibitor | 澳门大学 | 2022-07-29 | — | — | CN | claimed |
| US-20260083663-A1 | BOTANICAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | ARKANSAS STATE UNIV JONESBORO (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2024054685-A2 | BOTANICAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | ARKANSAS STATE UNIVERSTIY-JONESBORO (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20230190852-A1 | COMPOSITIONS AND METHODS FOR JOINT HEALTH | UNIGEN, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| CN-114796194-A | Application of DA adduct derived from Morus plant in preparation of beta-G inhibitor | 澳门大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-110117326-B | Xanthohumol-related protein and application thereof in stabilizing product in xanthohumol synthesis pathway | 中国科学院遗传与发育生物学研究所 | 2022-03-01 | — | — | CN | disclosed |
| CN-110117327-B | Xanthohumol-related protein and application thereof in preparation of product in xanthohumol synthesis pathway | 中国科学院遗传与发育生物学研究所 | 2022-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083663-A1 | BOTANICAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | SAMM50, SYMPK, CD69 | NPC1 3800/4885RAB9A 603/4885MAPT 1646/4885 |
| US-20230190852-A1 | COMPOSITIONS AND METHODS FOR JOINT HEALTH | PTGES, PTGES3, PTGES2 | NPC1 3203/4885RAB9A 3126/4885MAPT 4448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.